Embracing in her new documentary, legendary musician Sheryl Crow open She almost skipped a mammogram that later led to her being diagnosed with stage 1 ductal carcinoma in situ (DCIS), a form of breast cancer. The impending death that could have led to her death fueled her passion for breast cancer awareness.
The Centers for Disease Control and Prevention It is estimated that 255,000 cases of breast cancer are diagnosed each year in women and 2,300 in men. About 42,000 women and 500 men die in the United States each year from malignancy. Certain types of breast cancer, such as inflammatory breast cancer a favour They are considered “silent killers” because they progress quickly without the classic symptoms of breast cancer such as lumps.
The US Department of Health and Human Services It recommends that women over the age of 40 should have a mammogram every year to screen for cancer because early detection is key in treatment. However, according to National Center for Health StatisticsIn 2018, only 66.7% of women over 40 mentioned Obtaining a mammogram in the past two years, which puts 33.3% of women at risk of not knowing if they have some form of breast cancer.
Crowe would have been among the 33.3% had she not had a mammogram in the early 2000s. For some people, it may be easy to refuse the procedure because they don’t have a family history and are otherwise healthy, like Crowe. Now, Crowe advocates for screening women for breast cancer and has partnered with Genius 3D mamography to deliver 3D mammograms, a technology that’s effective in detecting cancers in people with dense breasts.
Tragic though it is, deaths from breast cancer can also help promote awareness of this devastating disease. Soap opera star Marni Schulenberg Passed away Wednesday at the age of 37 from breast cancer. She was diagnosed with stage 4 breast cancer on the eve of her 36th birthday, raising awareness of the diagnosis Instagram posts.
The news of younger patients battling and dying of breast cancer is perhaps the driving force for younger patients joining breast cancer trials. pointed visi That since 2014, the number of women under 60 years of age in clinical trials of breast cancer treatments has increased from 30% to 90%. Fizzy also believes that breast cancer screening efforts recommended in younger women may lead to a small increase.
Participation in clinical trials is very important so that individuals can benefit from new treatments under development. Thursday, Radius Health . announced that its oncogenic elacetrant met the primary endpoint of progression-free survival in phase III trials of patients with HER2-positive/HER2-negative breast cancer. At 12 months, treated patients had progression-free survival rates of 22.3% versus 9.4% of those treated with the current standard of care. Elacetrant also significantly reduced the risk of disease progression or death by 30% in all patients.
Other advances in breast cancer treatments include complementary Assent From AstraZeneca and Daiichi Sankyo’s Enhertu for early use in patients with unresectable or metastatic HER2-positive and promising breast cancer. Developments to BriaCellTherapeutic Bria-IMT that treats metastatic breast cancer.
However, men also need to participate in breast cancer clinical trials, and biopharmaceutical companies must include men in the trials. Although breast cancer is less common in men, there is new research Found The risk of invasive breast cancer in men may be related to self-reported infertility. In addition, some studies have Found Mortality rates for men are higher than women for all stages of breast cancer, possibly due to late diagnosis.
